2014-10-20 | Downgrade | Citigroup Inc. | Buy to Neutral | |
2014-09-29 | Reiterated Rating | Roth Capital | Positive | |
2014-09-29 | Downgrade | BMO Capital Markets | Outperform to Market Perform | |
2014-05-07 | Reiterated Rating | Citigroup Inc. | Buy | $17.00 to $14.00 |
2013-12-12 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $10.00 to $14.00 |
2013-12-04 | Reiterated Rating | Citigroup Inc. | Buy | |
2013-12-04 | Downgrade | BMO Capital Markets | Outperform to Market Perform | $24.00 to $10.00 |
2013-06-10 | Initiated | Robert W. Baird | Outperform | $14 |
2014-10-20 | Downgrade | Citigroup Inc. | Buy to Neutral | |
2014-09-29 | Reiterated Rating | Roth Capital | Positive | |
2014-09-29 | Downgrade | BMO Capital Markets | Outperform to Market Perform | |
2014-05-07 | Reiterated Rating | Citigroup Inc. | Buy | $17.00 to $14.00 |
2013-12-12 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $10.00 to $14.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AMBI 0 funds of 2213 total. Show all
Fund name | Ticker shares |
---|
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Foresite Capital Management I, LLC | 11.55% (2079569) | AMBI / |
FLEMING STANDISH | 5.37% (966146) | AMBI / |
ORBIMED ADVISORS LLC | 0.08% (14067) | AGLE / AMBI / ANTH / ATHX / BOLD / BONE / CRVS / CTIC / ICPT / KALA / LOXO / MRTX / OTIC / RLYP / ROKA / SIEN / SUPN / SYBX / XLRN / |
Bonita David P | 0.08% (14067) | AMBI / LOXO / |
ELMS STEVE | 0.01% (2362) | ADMA / AMBI / LOXO / PTX / |